HLAA Hosting a Webinar (April 8) and Convening a Meeting (May 25) with Permission from the FDA

HLAA will convene and host a Patient-Focused Drug Development (PFDD) meeting with permission from the Food and Drug Administration (FDA) on sensorineural hearing loss and its impact on daily life. All...HLAA will convene and host a Patient-Focused Drug Development (PFDD) meeting with permission from the Food and Drug Administration (FDA) on sensorineural hearing loss and its impact on daily life. All are welcome to attend. This session will be free and open to all. Look for more information to come. We will also hold an HLAA webinar on … Read More >

HLAA’s Concern for Consumers Reaches the FDA

Following the signing of the Over-the-Counter (OTC) Hearing Aid Act of 2017, the FDA was on track to issue regulations by the law’s deadline of August 2020. That deadline has...Following the signing of the Over-the-Counter (OTC) Hearing Aid Act of 2017, the FDA was on track to issue regulations by the law’s deadline of August 2020. That deadline has come and gone without new rules in place. During this period, bad actors have stepped in to fill this vacuum and begun to advertise OTC … Read More >